Dermapharm Holding SE (ETR: DMP)

Dermapharm Holding SE Revenue

Dermapharm Holding SE had revenue of 314.56M EUR in the quarter ending September 30, 2024, with 9.48% growth. This brings the company's revenue in the last twelve months to 1.17B, up 0.17% year-over-year. In the year 2023, Dermapharm Holding SE had annual revenue of 1.15B with 10.59% growth.

• Revenue (ttm): 1.17B
• Revenue Growth: +0.17%
• P/S Ratio: 1.75
• Revenue / Employee: 335.70K
• Employees: 3,497
• Market Cap: 2.05B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1.15B	110.19M	10.59%
Dec 31, 2022	1.04B	80.46M	8.38%
Dec 31, 2021	960.09M	151.78M	18.78%
Dec 31, 2020	808.31M	93.94M	13.15%
Dec 31, 2019	714.38M	130.28M	22.30%